• Non ci sono risultati.

Hyperglycaemic Hemichorea and Hyperglycaemic Hyperosmolar Syndrome in a Patient with HbA1c levels of 19.9%: A Rare and Potentially Reversible Case

N/A
N/A
Protected

Academic year: 2021

Condividi "Hyperglycaemic Hemichorea and Hyperglycaemic Hyperosmolar Syndrome in a Patient with HbA1c levels of 19.9%: A Rare and Potentially Reversible Case"

Copied!
2
0
0

Testo completo

(1)

European Journal

of Case Reports in

Internal Medicine

DOI: 10.12890/2019_001305 European Journal of Case Reports in Internal Medicine © EFIM 2019

Doi: 10.12890/2019_001305 - European Journal of Case Reports in Internal Medicine - © EFIM 2019

Hyperglycaemic Hemichorea and Hyperglycaemic Hyperosmolar

Syndrome in a Patient with HbA1c levels of 19.9%:

A Rare and Potentially Reversible Case

Mariana Guerra, Gonçalo Silva, Daniela Marado, Jorge Fortuna, Armando Carvalho Centro Hospitalar Universitário de Coimbra, Coimbra, Portugal

Received: 29/09/2019 Accepted: 08/10/2019 Published: 20/12/2019

How to cite this article: Guerra M, Silva G, Marado D, Fortuna J, Carvalho A. Hyperglycaemic hemichorea and hyperglycaemic hyperosmolar syndrome in a patient with HbA1c levels of 19.9%: a rare and potentially reversible case. EJCRIM 2019;7: doi:10.12890/2019_001305.

Conflicts of Interests: The Authors declare that there are no competing interest This article is licensed under a Commons Attribution Non-Commercial 4.0 License

ABSTRACT

Hemichorea is a rare clinical manifestation of type 2 diabetes mellitus. The patient presents with non-ketotic hyperglycaemia, hemichorea (characterized by rapid and involuntary movements of a specific part of the body) and the CT imaging reveals the presence of alterations involving the ganglia of the base[1-3].

LEARNING POINTS

• Hemichorea is a rare clinical manifestation of type 2 diabetes mellitus associated with an uncontrolled disease. • Hyperglycaemic hemichorea has a good prognosis.

• All diabetics need to maintain good metabolic control and control cardiovascular risk factors.

KEYWORDS

Diabetes mellitus, hyperglycaemic hyperosmolar syndrome, hyperglycaemic hemichorea

CASE DESCRIPTION

An 86-year-old woman, with a 20-year history of type 2 diabetes mellitus (DMT2) came to the ER due to motor agitation with involuntary movements of the left upper extremity with 3 days of evolution. She was apyretic, hypotensive and dehydrated. Involuntary, irregular and non-suppressible movements of the left superior member with involvement of the ipsilateral face were noted. The patient was found to be hyperglycaemic with a serum glucose of 1,045 mg/dl and also had hyperosmolar hyponatraemia, anaemia, leucocytosis with neutrophilia, acute renal injury and elevated troponin I, with non-supraST waves on the ECG. In the urine summary, the findings were of leucocyturia without ketonuria. Hyperglycaemic hyperosmolar syndrome and hyperglycaemic hemichorea were diagnosed. A CT scan was carried out (Fig. 1) with the identification of a hyperdensity at the level of the right striatum, which corroborated the neurological findings. Infusion with insulin therapy was started, and fluid therapy, as well as other supportive care directed towards the anaemia, acute cystitis and for the acute myocardial infarction type 2, was initiated. Antipsychotic medication was also needed. At the end of 3 days of hospitalization, the patient no longer presented involuntary movements and was discharged 6 days later. The glycated haemoglobin (HbA1c) result, however, was 19.9%.

(2)

European Journal

of Case Reports in

Internal Medicine

DOI: 10.12890/2019_001305 European Journal of Case Reports in Internal Medicine © EFIM 2019

Figure 1. Hyperdensity at the level of the right striatum

DISCUSSION

Most patients with hyperglycaemic hemichorea have a good prognosis, provided that they maintain good metabolic control, while therapy with dopaminergic antagonists may be necessary to control chorea[4]. This is a rare and revealing manifestation of the need for a high degree

of disease control, as evidenced by the HbA1c levels in our patient.

REFERENCES

1. Padmanabhan S, Zagami AS, Poynten AM. A case of hemichorea-hemiballismus due to nonketotic hyperglycemia. Diabetes Care 2013;36(4):e55–e56.

2. Cosentino C, Torres L, Nuñez Y, Suarez R, Velez M, Flores M. Hemichorea/hemiballism associated with hyperglycemia: report of 20 cases. Tremor Other Hyperkinet Mov (N Y) 2016;6:402.

3. Chang X, Hong W, Yu H, Yao Y. Chorea associated with nonketotic hyperglycemia: a case report with atypical imaging changes. Medicine 2017;96(45):e8602.

4. Ruhangisa F, Stephen H, Senkondo J, Mwasamwaja A, Kanenda S, Mbarak S, et al. Acute hemichorea in a newly diagnosed type II diabetes patient: a diagnostic challenge in resource-limited setting: a case report. BMC Res Notes 2016;9:413.

Riferimenti

Documenti correlati

The treatment of the product with acid conditions produces in sequence the deprotection of the aldehyde and the amine group and a final basic work-up brings

The measurements are compared to theoretical predictions from both proton parton distribution functions (PDFs) (CT14) and nuclear PDF (CT14+EPPS16 , CT14+nCTEQ15) sets.. The cross

Using the pig muscle, liver and kidney samples spiked with 1 m g/kg of OTA, the recovery obtained with the ED extraction method was higher and less variable than the recovery

zero del fondo e il punto di inizio scavo Lc meas Lunghezza adimensionale della buca di scavo. Lc calc Lunghezza della buca di scavo

Downloaded from.. Atrophic and hypertrophic fibers in the skeletal muscle of SBMA patients. A) Representative images of H&E-stained cryosections of control and SBMA

Le TAC rumorose sulle quali è stata applicata l’operazione di filtraggio e stima dei parametri cinetici sono state ottenute dalle curve tempo-attività presentate

Oltre ad avere un ruolo terapeutico e profilattico nel trattamento delle micosi anche aspergillari nella umana specie e negli animali, le molecole azoliche vengono

previously reported as a candidate gene for OAVS by linkage analysis, as well as previously unreported mutations in a number of new genes related to disorders with